Login
| TI Ref No : | 525474995 |
|---|---|
| Description : | The Aim Is To Conclude Discount Contracts For The Drug Natalizumab (form For Subcutaneous Injection) In Accordance With ยง 130a Abs. 8 Sgb V As Part Of An Open-house Procedure. The Participating Health Insurance Funds Pursue The Goal Of Concluding Discount |
| Date : | 2025-11-25 |
| Deadline : | 2026-05-24 |
| Document Type : | Tenders |
